Managing Clinical Trials and Drug Approvals in China
Add bookmark
Managing Clinical Trials and Drug Approvals in China
Add bookmark
China is now the world’s third-largest pharmaceutical market. In this interview Stefano Accorsi, Director, International Regulatory Affairs, International Comercial Operations, Chiesi Farmaceutici S.p.A, speaks to Andrea Charles from Pharma IQ, about the changes he has witnessed in the regulatory landscape in recent years and the key issues faced when managing clinical trials and drug approvals in China. Finally Accorsi shares his predictions for healthcare developments in China and their impact on foreign drug companies.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
Stefano Accorsi
Chiesi
China
China regulatory affairs
drug approvals China
regulatory affairs Asia
clinical trials China
